Jiangsu Pacific Meinuoke Bio-pharmaceutical Co., Ltd (PMBP) is a privately-owned company endeavoured to develop innovative and affordable biopharmaceuticals for patients with oncology and infectious diseases.

Our major services range from early target identification, lead identification and optimization to process development, GMP manufacturing, preclinical and clinical testing for global registration and marketing.

We aim to work collaboratively with major pharmaceutical companies worldwide for global development and marketing.

Our competitive advantage lies in our sustained close cooperation with National Translational Science Center for Molecular Medicine, which takes a leading role in basic research for innovative biopharmaceuticals in China. PMBP also maintains our competitiveness by enhancing technologies development for biopharmaceuticals, providing high-quality manufacturing, retaining our competence in non-clinical and clinical investigation, as well as vigorously handing regulatory affairs and marketing. With this approach, we are providing therapeutic medicine for patients with unmet needs and deem it as our ethical responsibility.

Our social responsibility is to provide high-quality affordable medicines to ensure efficient and safe treatments of patients.